Azmi Yerlikaya
Turkey Kutahya Health Sciences University
ORCID
Published in 2023
- Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa
- Authors: -
- Journal: Medical Oncology
ORCID
Published in 2023
- Molecular Pathways, Targeted Therapies, and Proteomic Investigations of Colorectal Cancer
- Authors: Azmi Yerlikaya, Sezgin Zeren
- Journal: Current Molecular Medicine
ORCID
Published in 2022
- Eksenatidin 3D 3T3-L1 Adipositleri Üzerindeki Ekspresyon Profilinin Mikrodizin Analizi ile Belirlenmesi
- Authors: -
- Journal: Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi
ORCID
Published in 2022
- Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations
- Authors: -
- Journal: Medical Oncology
ORCID
Published in 2021
- Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line
- Authors: Ertan Kanbur, Ahmet Tarık Baykal, Azmi Yerlikaya
- Journal: Medical Oncology
ORCID
Published in 2020
- The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer
- Authors: Azmi Yerlikaya, Ertan Kanbur, Bruce A. Stanley, Emrah Tümer
- Journal: Anti-Cancer Agents in Medicinal Chemistry
ORCID
Published in 2020
- The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells.
- Authors: Azmi Yerlikaya, Ertan Kanbur
- Journal: Current drug targets
ORCID
Published in 2020
- An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
- Authors: Azmi Yerlikaya, Emrah Okur
- Journal: Cytotechnology
ORCID
Published in 2018
- A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis.
- Authors: Emrah Okur, Azmi Yerlikaya
- Journal: Cell biology and toxicology
ORCID
Published in 2018
- Correction to: Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer (Breast Cancer Research and Treatment, (2018), 170, 2, (235-250), 10.1007/s10549-018-4752-8)
- Authors: Nuray Erin, Nur Ogan, Azmi Yerlikaya
- Journal: Breast Cancer Research and Treatment